KRISTIANA TWEED BURRELL

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ASHEVILLE, NC NPI 1386398337

General Payments — all program years on this page

$1,520.57

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 70
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $352.04 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $352.0420

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $60.843
Lilly USA, LLC $58.983
Novo Nordisk AS $49.103
Amgen Inc. $32.992
PFIZER INC. $31.572
Corcept Therapeutics $28.882
Indivior Inc. $22.381
Inari Medical, Inc. $17.681
Exact Sciences Corporation $17.101
Braeburn Inc. $16.871
SANOFI-AVENTIS U.S. LLC $15.651

By program year

Program yearAmountRecords
2022 $697.1734
2023 $471.3616
2024 $352.0420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100248080 Novo Nordisk Inc $17.58 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100452516 Novo Nordisk Inc $17.50 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100617938 Novo Nordisk Inc $14.02 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106853795 ABBVIE INC. $21.71 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106853797 ABBVIE INC. $25.22 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106853799 ABBVIE INC. $13.91 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114603521 Exact Sciences Corporation $17.10 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117214238 Amgen Inc. $14.96 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117517736 Amgen Inc. $18.03 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117768260 Corcept Therapeutics $14.18 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117768346 Corcept Therapeutics $14.70 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125616906 Braeburn Inc. $16.87 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131630991 PFIZER INC. $14.35 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132020273 PFIZER INC. $17.22 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135762003 Lilly USA, LLC $20.48 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135777672 Lilly USA, LLC $21.00 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135782220 Lilly USA, LLC $17.50 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139988319 SANOFI-AVENTIS U.S. LLC $15.65 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140180128 Inari Medical, Inc. $17.68 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144546133 Indivior Inc. $22.38 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.